Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Dispatch

Human Infection with Eurasian Avian-Like Swine Influenza A(H1N1) Virus, the Netherlands, September 2019

Anna Parys, Elien Vandoorn, Jacqueline King, Annika Graaf, Anne Pohlmann, Martin Beer, Timm Harder, and Kristien Van ReethComments to Author 
Author affiliations: Ghent University, Merelbeke, Belgium (A. Parys, E. Vandoorn, K. Van Reeth); Friedrich-Loeffler-Institut, Greifswald Insel-Riems, Germany (J. King, A. Graaf, A. Pohlmann, M. Beer, T. Harder)

Cite This Article

Abstract

We report a zoonotic infection of a pig farmer in the Netherlands with a Eurasian avian-like swine influenza A(H1N1) virus that was also detected in the farmed pigs. Both viruses were antigenically and genetically characterized. Continued surveillance of swine influenza A viruses is needed for risk assessment in humans and swine.

Eurasian avian-like swine influenza A(H1N1) viruses (IAVs) are entirely derived from a precursor virus of avian origin (1) and have been enzootic in the swine population in Europe since 1979 and in Asia since 1993. Zoonotic infections with such viruses, which are then termed H1N1 variant (H1N1v) viruses, occur sporadically. Most cases occur in humans who have direct exposure to pigs. Since 1986, several human cases of Eurasian avian-like H1N1 swine IAV have been reported in Europe (24) and China (3,5).

These events reflect the possibility of Eurasian avian-like H1N1 swine IAV transmission from swine to humans. In this study, we report an infection with a Eurasian avian-like H1N1 swine IAV in a pig farmer and his pigs in a herd in the Netherlands. We also conducted whole-genome characterization of viruses from the man and the pigs.

The Study

On September 18, 2019, acute respiratory disease was observed in a 43-year-old man (farmer) and his 14-week-old fattening pigs and gilts. The pigs of this closed farm showed coughing, anorexia, tachypnea, dyspnea, and lethargy. Two days earlier, a 44-year-old man (animal caretaker) had reported similar symptoms. The sows of this herd (n = 420) were vaccinated against swine IAVs with Respiporc FLU3 vaccine (Ceva, https://www.ceva.com), but the farmer and animal caretaker were not recently vaccinated against human seasonal influenza viruses. Both humans and the pigs recovered completely within 10 days after the first appearance of signs or symptoms. Family members and close contacts of the men did not show development of influenza-like symptoms.

Six days after onset of disease, nasal swab samples were collected from the farmer, the animal caretaker, and 6 symptomatic pigs. Human samples were collected by self-sampling, and informed consent was obtained from the farmer and the animal caretaker. Subsequently, samples were shipped to the Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University (Merelbeke, Belgium).

Upon inoculation into MDCK cells, IAV was isolated from the sample of the farmer and from a pooled sample of the pigs; no virus was isolated from the animal caretaker. Public health authorities in the Netherlands were notified about the H1N1v infection. The human H1N1v isolate was named A/Netherlands/Gent-193/2019, and the swine H1N1 isolate was named A/swine/Netherlands/Gent-193/2019.

Virus neutralization tests with swine antiserum against swine IAVs of the H1N1, H1N2, and H3N2 subtypes showed an antigenic relationship between both newly discovered isolates and Eurasian avian-like H1N1 swine IAVs from 1998 and 2010, as well as the prototype influenza A(H1N1)pdm09 (pH1N1) A/California/04/2009 virus. Serologic cross-reactivity with H1N2 or H3N2 swine IAVs was not observed (Table 1).

Figure

Phylogenetic tree based on amino acid sequences of the hemagglutinin 1 of Eurasian avian-like swine influenza A(H1N1) virus isolates from a pig farmer and his pigs (green circles), the Netherlands, and reference sequences (see Table 2). Red triangles indicate reference sequences from humans. Phylogenetic relationships were estimated by using the maximum-likelihood method in MEGA7 software (https://www.megasoftware.net) and the Jones-Taylor-Thornton substitution model with a gamma distribution of among-site rate. Branch length is proportional to genetic distance. Scale bar indicates amino acid substitutions per site.

Figure. Phylogenetic tree based on amino acid sequences of the hemagglutinin 1 of Eurasian avian-like swine influenza A(H1N1) virus isolates from a pig farmer and his pigs (green circles), the Netherlands,...

Initial analyses by multiplex real-time reverse transcription PCRs (6) and whole-genome next-generation sequencing (7) of both isolates confirmed that all genome segments were closely related to those of Eurasian avian-like H1N1 swine IAVs. A BLAST homology search (http://www.fludb.org) with both whole genomes showed highest nucleotide identities (96%) for hemagglutinin (HA) and neuraminidase with clade 1C.2.2 Eurasian avian-like H1N1 swine IAVs isolated in Germany and the Netherlands during 2011–2012. These databases contain limited numbers of sequences of this swine IAV clade, which explains the lack of similar recent viruses. A phylogenetic tree of Eurasian avian-like H1N1 swine IAVs isolated in Europe and Asia was constructed by using MEGA7 software (https://www.megasoftware.net). Phylogenetic analysis confirmed the genetic relationship of the HA1 genes of both isolates with Eurasian avian-like H1N1 swine IAVs of clade 1C.2.2 (Table 2; Figure).

The human H1N1v and swine H1N1 isolates differed in several positions in the genes coding for the 3 polymerase proteins (polymerase basic [PB] 2, PB1, and polymerase acidic), the HA gene, and the nonstructural protein gene. The other 3 gene segments (neuraminidase, nucleoprotein, and matrix) were 100% identical. HA gene sequences of the swine H1N1 and the human H1N1v isolates showed amino acid substitutions K142N, N195S, and V215I (H1 numbering). Position 142 is located in antigenic site Ca2 and position 195 in antigenic site Sb (8). In human seasonal influenza A(H1N1) viruses, a substitution at position 142 was reported to cause antigenic change (9). This substitution might explain the loss of reactivity with pH1N1 antiserum for the human H1N1v isolate versus the swine H1N1 isolate (Table 1). In addition, in H5 IAVs this substitution decreased the pH at which the HA underwent fusion (10).

Because human-adapted viruses undergo fusion at a lower pH (5.0–5.5) than swine-adapted and avian-adapted viruses (pH 5.6–6.0), such mutations might contribute to human adaptation of zoonotic viruses. We found multiple substitutions in the polymerase genes of the human H1N1v isolate: R739Q in PB2, L108I and T652A in PB1, and D682N in polymerase acidic. Based on analyses in the FluSurver database (https://flusurver.bii.a-star.edu.sg/), the R739Q substitution in the PB2 gene might influence the binding of PB2 to host protein(s). We also found 2 substitutions in the nonstructural protein gene: V18I and G227R. Sequences were made publicly available in GenBank (accession nos. MT395362–77), and GISAID (https://www.gisaid.org; accession nos. EPI_ISL_430866 [A/swine/Netherlands/Gent-193/2019] and EPI_ISL_0865 [A/Netherlands/Gent-193/2019]).

Conclusions

We report another zoonotic infection with a Eurasian avian-like H1N1 swine IAV in Europe since the emergence of the virus in 1979 (24). No further human-to-human transmission was reported, although it cannot be excluded that the farmer was infected by the animal caretaker. The nasal swab sample from the caretaker might have tested negative because it was collected as late as 8 days after he reported influenza-like symptoms.

The swine antiserum against the pH1N1 virus cross-reacted with the swine H1N1 isolate from this investigation (Table 1) but had a 192-fold lower virus neutralization titer against the human H1N1v isolate. Therefore, it is unlikely that current human seasonal vaccines would provide cross-protection against the human H1N1v isolate. This finding is consistent with our recent investigations of human serum samples for antibodies against 8 H1 swine IAVs representing 7 predominant H1 clades of swine IAVs; only 55 (10%) of 549 human serum samples had hemagglutination inhibition titers >40 against a European avian-like H1N1 swine IAV of clade 1C.2.1, which is predominant in swine in Europe (11), compared with 24%–54% against 5 other clades (12). These data point toward a relatively greater zoonotic risk for avian-like H1N1 swine IAVs from Europe and are consistent with previous studies about Eurasian avian-like H1N1 swine IAVs from China (5,13). Our data further support the notion that Eurasian avian-like H1N1 swine IAVs need to be monitored closely.

We found several amino acid substitutions between the H1N1 swine isolate and the H1N1v human isolate, but their role remains obscure. The past 2 decades have seen an unprecedented increase of data for putative mammalian-adaptive mutations of avian influenza viruses. The known genetic markers are mainly based on studies with wholly avian viruses of various HA subtypes in mammalian cell culture or in ferrets. Knowledge of amino acid substitutions that might enable adaptation of swine-adapted influenza viruses to humans, in contrast, is almost nonexistent (14). This finding is true for Eurasian avian-like H1N1 swine IAVs, as well as for the pH1N1 virus, which is the only known swine-origin virus with the ability to spread efficiently between humans. Our study highlights the need for experimental research on this topic and for continued surveillance of swine IAVs because of the risk for human infection or zoonotic spread.

Ms. Parys is a PhD student in the Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. Her primary research interests are the pig as a model for development of broadly protective influenza A vaccines and public health implications of swine influenza.

Top

Acknowledgments

We thank the farmer, animal caretaker, and veterinarian for their cooperation and Nele Dennequin and Melanie Bauwens for providing technical assistance.

This study was supported by the University of Ghent Research Fund Bijzonder OnderzoeksFonds (grant no. 01J102017) and the European Union Horizon 2020 Research and Innovation Programme (grant no. 727922 DELTA-FLU).

Top

References

  1. Pensaert  M, Ottis  K, Vandeputte  J, Kaplan  MM, Bachmann  PA. Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bull World Health Organ. 1981;59:758.PubMed
  2. Freidl  GS, Meijer  A, de Bruin  E, de Nardi  M, Munoz  O, Capua  I, et al.; FLURISK Consortium. Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill. 2014;19:20793. DOIPubMed
  3. World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness [cited 2020 Jun 18]. https://www.who.int/influenza/vaccines/virus/202009_zoonotic_vaccinevirusupdate.pdf
  4. European Centre for Disease Prevention and Control. Update: swine-origin triple reassortant influenza A(H3N2) variant viruses in North America, 2012. Stockholm: The Centre [cited 2020 Dec 9]. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/publications/1208-ter-rapid-risk-assessment-influenza-ah3n2-us.pdf
  5. Sun  H, Xiao  Y, Liu  J, Wang  D, Li  F, Wang  C, et al. Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection. Proc Natl Acad Sci U S A. 2020;117:1720410. DOIPubMed
  6. Henritzi  D, Zhao  N, Starick  E, Simon  G, Krog  JS, Larsen  LE, et al. Rapid detection and subtyping of European swine influenza viruses in porcine clinical samples by haemagglutinin- and neuraminidase-specific tetra- and triplex real-time RT-PCRs. Influenza Other Respir Viruses. 2016;10:50417. DOIPubMed
  7. King  J, Schulze  C, Engelhardt  A, Hlinak  A, Lennermann  SL, Rigbers  K, et al. Novel HPAIV H5N8 reassortant (Clade 2.3.4.4b) detected in Germany. Viruses. 2020;12:17. DOIPubMed
  8. Brownlee  GG, Fodor  E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci. 2001;356:18716. DOIPubMed
  9. Harvey  WT, Benton  DJ, Gregory  V, Hall  JPJ, Daniels  RS, Bedford  T, et al. Identification of low- and high-impact hemagglutinin amino acid substitutions that drive antigenic drift of influenza A (H1N1) viruses. PLoS Pathog. 2016;12:e1005526. DOIPubMed
  10. Rudneva  IA, Timofeeva  TA, Ignatieva  AV, Shilov  AA, Krylov  PS, Ilyushina  NA, et al. Pleiotropic effects of hemagglutinin amino acid substitutions of H5 influenza escape mutants. Virology. 2013;447:2339. DOIPubMed
  11. Anderson  TK, Macken  CA, Lewis  NS, Scheuermann  RH, Van Reeth  K, Brown  IH, et al. A phylogeny-based global nomenclature system and automated annotation tool for H1 hemagglutinin genes from swine influenza A viruses. MSphere. 2016;1:e0027516. DOIPubMed
  12. Vandoorn  E, Leroux-Roels  I, Leroux-Roels  G, Parys  A, Vincent  A, Van Reeth  K. Detection of H1 swine influenza A virus antibodies in human serum samples by age group. Emerg Infect Dis. 2020;26:211828. DOIPubMed
  13. Yang  H, Chen  Y, Qiao  C, He  X, Zhou  H, Sun  Y, et al. Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses. Proc Natl Acad Sci U S A. 2016;113:3927. DOIPubMed
  14. Pulit-Penaloza  JA, Belser  JA, Tumpey  TM, Maines  TR. Sowing the seeds of a pandemic? Mammalian pathogenicity and transmissibility of H1 variant influenza viruses from the swine reservoir. Trop Med Infect Dis. 2019;4:121. DOIPubMed

Top

Figure
Tables

Top

Cite This Article

DOI: 10.3201/eid2703.201863

Original Publication Date: February 09, 2021

Table of Contents – Volume 27, Number 3—March 2021

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Kristien Van Reeth, Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium

Send To

10000 character(s) remaining.

Top

Page created: December 10, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external